ADMA BIOLOGICS, INC. Contracts & Agreements

Employment Agreement, dated July 24, 2024, by and between the Company and Brad Tade (Filed With SEC on July 26, 2024)

Employment Agreement, dated April 1, 2024, by and between the Company and Kaitlin Kestenberg (Filed With SEC on April 2, 2024)

Consulting Agreement, dated February 27, 2024, by and between the Company and Mr. Brian Lenz (Filed With SEC on February 28, 2024)

Form of Warrant to Purchase Common Stock (Filed With SEC on May 2, 2023)

Amendment No. 2 to the Credit and Guaranty Agreement, dated as of May 1, 2023 (Filed With SEC on May 2, 2023)

Amendment No. 1 to Credit Agreement and Guaranty, dated March 23, 2023 by and among the Company, Hayfin Services LLP and the lenders party thereto (Filed With SEC on March 23, 2023)

Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc., as representative of the several underwriters named therein, dated as of December 7, 2022 (Filed With SEC on December 7, 2022)

Amendment 4 to the Amended and Restated Agreement For Services Between ADMA BioManufacturing, LLC and Areth LLC (Filed With SEC on November 9, 2022)

ADMA Biologics, Inc. 2022 Equity Compensation Plan (Filed With SEC on June 21, 2022)

Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 24, 2022)

Form of Warrant to Purchase Stock, in the form issued by the Company to various entities affiliated with Hayfin Services LLP, dated as of March 23, 2022 (Filed With SEC on March 24, 2022)

Credit Agreement and Guaranty, dated as of March 23, 2022, by and among the Company, Hayfin Services LLP and the lenders party thereto (Filed With SEC on March 24, 2022)

Security Agreement, dated as of March 23, 2022, by and among the Company, certain subsidiaries of the Company and Hayfin Services LLP (Filed With SEC on March 24, 2022)

Rights Agreement, dated as of December 20, 2021, by and between ADMA Biologics, Inc. and Continental Stock Transfer and Trust Company, as rights agent (Filed With SEC on December 21, 2021)

Underwriting Agreement, by and between the Company and Raymond James & Associates, Inc., as representative of the several underwriters named therein, dated as of October 21, 2021 (Filed With SEC on October 21, 2021)

Form of Retention Bonus Agreement (Filed With SEC on October 1, 2021)

Amendment to Employment Agreement, dated as of September 29, 2021, by and between the Company and Adam Grossman (Filed With SEC on October 1, 2021)

Amendment to Employment Agreement, dated as of September 29, 2021, by and between the Company and Brian Lenz (Filed With SEC on October 1, 2021)

Distribution Agreement, dated September 3, 2021, by and between ADMA Biologics, Inc. and Raymond James & Associates, Inc (Filed With SEC on September 3, 2021)

Separation Agreement and Release, dated August 6, 2021, by and between ADMA Biologics, Inc. and James Mond (Filed With SEC on August 11, 2021)

Open Market Sale AgreementSM, dated May 28, 2021, by and between ADMA Biologics, Inc. and Jefferies LLC (Filed With SEC on May 28, 2021)

Second Amendment to Plasma Purchase Agreement, effective as of May 12, 2021, by and between ADMA BioManufacturing, LLC and Grifols Worldwide Operations LTD (Filed With SEC on May 12, 2021)

Warrant to Purchase Stock, dated December 8, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on March 25, 2021)

Description of Securities Registered under Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 25, 2021)

Amendment No. 2 to Sale Agreement, dated as of February 3, 2021 (Filed With SEC on February 3, 2021)

Rights Agreement, dated as of December 16, 2020, by and between ADMA Biologics, Inc. and Continental Stock Transfer and Trust Company, as rights agent (Filed With SEC on December 16, 2020)

Note, dated December 8, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on December 9, 2020)

Amendment No. 2 to Credit Agreement and Guaranty, dated December 8, 2020 (Filed With SEC on December 9, 2020)

Amendment to Open Market Sale AgreementSM, dated November 5, 2020, by and between ADMA Biologics, Inc. and Jefferies LLC (Filed With SEC on November 5, 2020)

Open Market Sale AgreementSM, dated August 5, 2020, by and between ADMA Biologics, Inc. and Jefferies LLC (Filed With SEC on August 5, 2020)

Note, dated March 20, 2020, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on March 20, 2020)

Description of Capital Stock of ADMA Biologics, Inc (Filed With SEC on March 13, 2020)

Amendment 1 to the Amended and Restated Agreement for Services, effective as of September 25, 2017, by and between ADMA Biologics, LLC and Areth LLC (Filed With SEC on March 13, 2020)

Amendment 2 to the Amended and Restated Agreement for Services, effective as of September 27, 2018, by and between ADMA Biologics, LLC and Areth LLC (Filed With SEC on March 13, 2020)

Amendment 3 to the Amended and Restated Agreement for Services, effective as of November 7, 2019, by and between ADMA Biologics, LLC and Areth LLC (Filed With SEC on March 13, 2020)

Underwriting Agreement by and among the Company and the Underwriters dated as of February 6, 2020 (Filed With SEC on February 7, 2020)

Amendment #1 to Transition Services Agreement, dated as of August 29, 2019, by and between ADMA Biomanufacturing, LLC and Biotest Pharmaceuticals Corporation (Filed With SEC on September 5, 2019)

Underwriting Agreement by and among the Company and the Underwriters dated as of May 16, 2019 (Filed With SEC on May 17, 2019)

Note, dated May 3, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on May 3, 2019)

Warrant to Purchase Stock, dated May 3, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on May 3, 2019)

Amendment No. 1 to Credit Agreement and Guaranty, dated as of May 3, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA... (Filed With SEC on May 3, 2019)

Transition Services Agreement, dated as of January 1, 2019, by and between the Company and Biotest Pharmaceuticals Corporation (Filed With SEC on March 13, 2019)

Note, dated February 11, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on February 12, 2019)

Warrant to Purchase Stock, dated February 11, 2019, issued by the Company to Perceptive Credit Holdings II, LP (Filed With SEC on February 12, 2019)

Security Agreement, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and Perceptive... (Filed With SEC on February 12, 2019)

Credit Agreement and Guaranty, dated as of February 11, 2019, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, and... (Filed With SEC on February 12, 2019)

Amended and Restated Employment Agreement, dated as of January 29, 2019, by and between ADMA Biologics, Inc. and Adam Grossman (Filed With SEC on January 29, 2019)

Amended and Restated Employment Agreement, dated as of January 29, 2019, by and between ADMA Biologics, Inc. and Dr. James Mond (Filed With SEC on January 29, 2019)

Amended and Restated Employment Agreement, dated as of January 29, 2019, by and between ADMA Biologics, Inc. and Brian Lenz (Filed With SEC on January 29, 2019)

Fifth Amendment to Plasma Purchase Agreement, effective as of January 1, 2019, by and between ADMA Biologics, Inc. and Grifols Worldwide Operations Limited (Filed With SEC on January 2, 2019)

Share Transfer, Amendment and Release Agreement, dated as of May 14, 2018, by and among Biotest Pharmaceuticals Corporation, Biotest AG, The Biotest Divestiture Trust, Biotest US... (Filed With SEC on August 10, 2018)

Amendment #1 to the Plasma Supply Agreement, dated as of July 19, 2018, by and between Biotest Pharmaceuticals Corporation and ADMA BioManufacturing, LLC (Filed With SEC on August 10, 2018)

Amendment to Plasma Purchase Agreement, dated as of July 19, 2018, by and between Biotest Pharmaceuticals Corporation and ADMA BioManufacturing, LLC (Filed With SEC on August 10, 2018)

Assignment and Assumption Agreement (ADMA Loan), dated as of July 20, 2018, by and among Biotest AG, Biotest Pharmaceuticals Corporation, ADMA BioManufacturing, LLC and ADMA... (Filed With SEC on July 24, 2018)

Agreement to Transfer Land, dated as of July 20, 2018, by and among Biotest Real Estate Corp., Biotest AG, Biotest Pharmaceuticals Corporation, ADMA BioManufacturing, LLC and ADMA... (Filed With SEC on July 24, 2018)

Underwriting Agreement by and among the Company and the Underwriters dated as of June 8, 2018 (Filed With SEC on June 8, 2018)

Manufacturing Agreement, dated as of September 30, 2011, by and between ADMA BioManufacturing, LLC (as successor-in-interest to Biotest Pharmaceuticals Corporation) and Sanofi... (Filed With SEC on March 29, 2018)

Amendment #2 to the Manufacturing Agreement, effective as of August 1, 2016, by and between ADMA BioManufacturing, LLC (as successor-in-interest to Biotest Pharmaceuticals... (Filed With SEC on March 29, 2018)

Amendment #3 to the Manufacturing Agreement, effective as of December 21, 2017, by and between ADMA BioManufacturing, LLC and Sanofi Pasteur S.A (Filed With SEC on March 29, 2018)

Underwriting Agreement, dated as of November 8, 2017, by and between the Company and Raymond James & Associates, Inc., as representatives of the several underwriters (Filed With SEC on November 9, 2017)

Form of Underwriting Agreement (Filed With SEC on November 3, 2017)

Tranche One Term Note, dated October 10, 2017, issued by the Company to Marathon Healthcare Finance Fund, L.P (Filed With SEC on October 11, 2017)

Warrant to Purchase Stock, dated October 10, 2017, issued by the Company to Marathon Healthcare Finance Fund, L.P (Filed With SEC on October 11, 2017)

Credit Agreement, dated as of October 10, 2017, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC, Marathon... (Filed With SEC on October 11, 2017)

Security Agreement, dated as of October 10, 2017, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA BioManufacturing, LLC and Wilmington... (Filed With SEC on October 11, 2017)

Intellectual Property Security Agreement, dated as of October 10, 2017, by and among the Company, ADMA Plasma Biologics, Inc., ADMA Bio Centers Georgia Inc., ADMA... (Filed With SEC on October 11, 2017)

Pledge Agreement, dated as of October 10, 2017, by and between the Company and Wilmington Trust, National Association (Filed With SEC on October 11, 2017)

TRANSITIONSERVICES AGREEMENT by and between ADMA BIOMANUFACTURING,LLC and BIOTEST PHARMACEUTICALSCORPORATION Dated as ofJune 6, 2017 (Filed With SEC on August 11, 2017)

PLASMA SUPPLY AGREEMENT (HEPATITIS B PLASMA - BPCTO ADMA) (Filed With SEC on August 11, 2017)

PLASMAPURCHASE AGREEMENT NORMAL SOURCE PLASMA PURCHASEFROM BPC TO ADMA (Filed With SEC on August 11, 2017)

PURCHASEAGREEMENT (Filed With SEC on August 11, 2017)

FIRST AMENDMENT TO LICENSEAGREEMENT (Filed With SEC on August 11, 2017)

FOURTH AMENDMENT TO PLASMAPURCHASE AGREEMENT (Filed With SEC on August 11, 2017)

TERMINATIONAGREEMENT (MANUFACTURING,SUPPLY AND LICENSE AGREEMENT AND MASTER SERVICES AGREEMENT) (Filed With SEC on August 11, 2017)

SUBORDINATED LOAN AGREEMENT (Filed With SEC on June 12, 2017)

STOCKHOLDERS AGREEMENT by and among ADMA Biologics, Inc., Biotest Pharmaceuticals Corporation and Such other Persons who become party heretopursuant to Section 4.1(c)... (Filed With SEC on June 12, 2017)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 12, 2017)

LEASE 166 EARNEST W. BARRETT PARKWAY MARIETTA, GA 30066 KENNESAW MARKET By and Between HOME CENTER PROPERTIES, LLC, a Georgia limited liability company (“Landlord”) and ADMA... (Filed With SEC on February 24, 2017)

AMENDED AND RESTATED AGREEMENT FOR SERVICES BETWEEN ADMA BIOLOGICS Inc. AND ARETH LLC AMENDED AND RESTATED (Filed With SEC on August 12, 2016)

WARRANT [___] TO PURCHASE STOCK (Filed With SEC on May 13, 2016)

SECURED PROMISSORY NOTE (TermB-[___] Loan) $[___] Dated:May 13, 2016 (Filed With SEC on May 13, 2016)

THIRD AMENDMENT TO PLASMA PURCHASE AGREEMENT (Filed With SEC on May 13, 2016)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on May 13, 2016)

1,892,308 Shares* ADMA Biologics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 28, 2016)

WARRANT [] TO PURCHASE STOCK (Filed With SEC on March 23, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 23, 2016)

Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 under the... (Filed With SEC on March 23, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 23, 2016)

Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 under the... (Filed With SEC on March 23, 2016)

AMENDED AND RESTATED EMPLOYMENT AGREEMENT (Filed With SEC on March 23, 2016)

LOAN AND SECURITY AGREEMENT (Filed With SEC on August 11, 2015)

Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 under the... (Filed With SEC on May 12, 2015)

1,225,000Shares* (Filed With SEC on March 13, 2015)

LEASE Confidential Materials Omitted and Filed Separately with the U.S. Securities and Exchange Commission Confidential Portions denoted by [***] NOTICE: (Filed With SEC on March 28, 2014)

FIRST AMENDMENT TO LOAN AND SECURITY AGREEMENT (Filed With SEC on March 28, 2014)

[______________] Shares ADMA Biologics, Inc. Common Stock FORM OF UNDERWRITING AGREEMENT (Filed With SEC on April 22, 2013)

[______________] Shares ADMA Biologics, Inc. Common Stock UNDERWRITING AGREEMENT (Filed With SEC on April 8, 2013)

WARRANT AGREEMENT To Purchase Shares of the Common Stock of ADMA Biologics, Inc. Dated as of December 21, 2012 (the "Effective Date") (Filed With SEC on February 11, 2013)

SECURED TERM LOAN PROMISSORY NOTE (Filed With SEC on February 11, 2013)

LOAN AND SECURITY AGREEMENT (Filed With SEC on February 11, 2013)

EQUITY RIGHTS LETTER (Filed With SEC on February 11, 2013)

Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 406 under the... (Filed With SEC on February 11, 2013)

LICENSE AGREEMENT (Filed With SEC on February 11, 2013)

ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] Testing Services... (Filed With SEC on August 10, 2012)

ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] PLASMA SUPPLY AGREEMENT (Filed With SEC on August 10, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2012)

ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] Testing Services... (Filed With SEC on July 3, 2012)

ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] PLASMA SUPPLY AGREEMENT (Filed With SEC on July 3, 2012)

ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] Amendment #2 to the... (Filed With SEC on June 22, 2012)

ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] (Filed With SEC on June 22, 2012)

PLACEMENT AGENCY MODIFICATION AND RELEASE AGREEMENT (Filed With SEC on June 21, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on May 3, 2012)

AMENDMENT NO. 2 TO THE ADMA BIOLOGICS, INC. 2007 STOCK OPTION PLAN (Filed With SEC on March 29, 2012)

AGREEMENT FOR SERVICES BETWEEN ADMA BIOLOGICS LLC AND ARETH Inc. AGREEMENT FOR PROFESSIONAL SERVICES TABLE OF CONTENTS (Filed With SEC on March 29, 2012)

AGREEMENT AND PLAN OF MERGER BY AND AMONG R&R ACQUISITION VI, INC., ADMA BIOLOGICS, INC. AND ADMA ACQUISITION SUB, INC. (Filed With SEC on February 13, 2012)

FORM OF COMMON STOCK PURCHASE WARRANT ADMA BIOLOGICS, INC. Warrant Shares: 87,865Initial Exercise Date: August 11, 2012Issue Date: February 13, 2012 (Filed With SEC on February 13, 2012)

ADMA BIOLOGICS, INC. 2007 EMPLOYEE STOCK OPTION PLAN (Filed With SEC on February 13, 2012)

FORM OF SECURITIES PURCHASE AGREEMENT (Filed With SEC on February 13, 2012)

FORM OF REGISTRATION RIGHTS AGREEMENT (Filed With SEC on February 13, 2012)

AMENDED AND RESTATED PLACEMENT AGENCY AGREEMENT February 12, 2012 (Filed With SEC on February 13, 2012)

FORM OF LOCK-UP AGREEMENT (Filed With SEC on February 13, 2012)

EMPLOYMENT AGREEMENT (Filed With SEC on February 13, 2012)

INVESTORS RIGHTS AGREEMENT TABLE OF CONTENTS (Filed With SEC on February 13, 2012)

ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] Amendment #2 to the... (Filed With SEC on February 13, 2012)

ADMA Biologics, Inc. Confidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Confidential Portions denoted by [***] PLASMA PURCHASE... (Filed With SEC on February 13, 2012)

AGREEMENT FOR SERVICES BETWEEN ADMA BIOLOGICS LLC AND ARETH Inc. AGREEMENT FOR PROFESSIONAL SERVICES TABLE OF CONTENTS (Filed With SEC on February 13, 2012)

AGREEMENT OF LEASE (Filed With SEC on February 13, 2012)

FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on February 13, 2012)

Category

Industry

Companies

Contracts

ADMA BIOLOGICS, INC. Contracts & Agreements